Hyaluronidase (Human Recombinant)
ATC B06AA03 · 2 markets · 23 records
Hyaluronidase (Human Recombinant)
Forms
US 18 records · 10 strengths
- 30,000 unit/15 mLinjectionDarzalex FasproPhesgo、Tecentriq Hybreza
- 2,000 unitinjectionOPDIVO QVANTIGRituxan Hycela、VYVGART Hytrulo
- 23,000 unit/23 mLinjectionOcrevus Zunovo
- 20,000 unit/10 mLinjectionPhesgo
- 10,000 unit/5 mLinjectionHerceptin Hylecta
- 44,000 mg/22 mLinjectionRybrevant Faspro
- 30,000 mg/15 mLinjectionRybrevant Faspro
- 28,000 mg/14 mLinjectionRybrevant Faspro
- 20,000 mg/10 mLinjectionRybrevant Faspro
Records without a stated strength · 1 HYLENEX Recombinant、Manufacturer: HF Acquisition Co LLC, DBA …
CA 5 records · 1 strengths
- 160 unit/1 mLliquidHYQVIA
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.